61023-50-5

1H-Imidazole, 1-(1-methyl-1-phenylpentyl)-

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)-, monosodium salt

Cyclopropanecarboxylic acid,3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-,2,3-dihydro-4-(phenylmethyl)-1H-inden-2-yl ester

1,8-Naphthyridin-4(1H)-one,3-[4-ethyl-4,5-dihydro-1-(4-morpholinylmethyl)-5-thioxo-1H-1,2,4-triazol-3-yl]-7-methyl-

Imidazo[1,2-a]pyridine, 6-ethenyl-7-fluoro-

methyl 3-(bromomethyl)-4-fluorobenzoate

1,8-Naphthyridin-4(1H)-one,2-[(4-methoxyphenyl)amino]-7-methyl-1-phenyl-

1,8-Naphthyridin-2(1H)-one,4-hydroxy-3-(8-hydroxy-5-methyl-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-1-(phenylmethyl)-

1,8-Naphthyridin-4(1H)-one, 5,7-dimethyl-1-phenyl-2-(phenylamino)-

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-[3-(4-methyl-1-piperazinyl)propyl]-, dihydrochloride

Imidazo[1,2-a]pyridine, 6-ethyl-7-methoxy-

1H-Azepine,4-[[[3,5-bis(trifluoromethyl)phenyl]methoxy]methyl]hexahydro-4-phenyl-1-(phenylmethyl)-, (4S)-

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-[(1S)-1-phenylethyl]-

1H-Azepine-4,5-diol, hexahydro-4-methyl-1-[(4-methylphenyl)sulfonyl]-,(4R,5S)-rel-

1,8-Naphthyridin-2(1H)-one,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-[(3-iodophenyl)methyl]-

1H-Azepine,hexahydro-1-[[5-[(4-methyl-1-piperidinyl)sulfonyl]-1H-indol-2-yl]carbonyl]-

1,8-Naphthyridin-4(1H)-one,3-[1-[(diethylamino)methyl]-4,5-dihydro-5-oxo-4-phenyl-1H-1,2,4-triazol-3-yl]-7-methyl-

1H-Indazole,3-[5-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-1H-benzimidazol-2-yl]-5-fluoro-, rel-

1H-Azepine-4,5-dicarboxylic acid,3,6-dichloro-1-[(4-methylphenyl)sulfonyl]-, dimethyl ester

1,8-Naphthyridin-4(1H)-one, 7-methyl-2-(methylthio)-1-phenyl-

1H-3-Benzazepine-7,8-diol,6-bromo-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-3-(2-propenyl)-

1H-Azepine,hexahydro-1-[[3-[(3-thienylmethyl)sulfonyl]-1H-1,2,4-triazol-1-yl]carbonyl]-

1,8-Naphthyridin-4(1H)-one,5-ethyl-6-fluoro-1-(4-fluorophenyl)-2-[(4-fluorophenyl)amino]-

1H-7l4-[1,2]Dithiolo[5,1-e][1,2,3]thiadiazole,3-bromo-1-(4-bromophenyl)-

1,8-Naphthyridin-2(1H)-one, 4-(2-chlorophenyl)-1-ethyl-7-methyl-

Benzoic acid, 3-(1-cyano-1-methylethyl)-5-[(dimethylamino)methyl]-

1H-Azepine-1-acetamide, hexahydro-2-oxo-N,N-diphenyl-

1,8-Naphthyridin-2(1H)-one,4-hydroxy-3-[7-[(methoxymethoxy)methyl]-1,1-dioxido-2H-thieno[2,3-e]-1,2,4-thiadiazin-3-yl]-1-(3-methylbutyl)-

1,8-Naphthyridin-2(1H)-one, 4-hydrazino-, hydrazone

1H-Azepine-1-carboxylic acid, phenyl ester

1,8-Naphthyridin-4(1H)-one,1-[3-(dimethylamino)propyl]-2,3-dihydro-7-methyl-,(4-chlorophenyl)hydrazone, dihydrochloride

1H-Azepine,hexahydro-3,5,5-trimethyl-1-[2-methyl-3-[4-(1-methylethyl)phenyl]propyl]-

1,8-Naphthyridin-2-amine,5,6,7,8-tetrahydro-4,5,5-trimethyl-N,8-bis(2,4,6-trimethylphenyl)-

Cyclopropanemethanol,2-[(2-amino-6-chloro-9H-purin-9-yl)methyl]-2-fluoro-, (1R,2R)-rel-

1H-3-Benzazepine-7,8-diol,6-fluoro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-3-methyl-, hydrobromide

Ethanedial, mono[(4-nitrophenyl)hydrazone]

1,8-Naphthyridin-4(1H)-one,5-(2,2-difluoroethoxy)-7-methyl-1-phenyl-2-(phenylamino)-

61023-50-5 msds

CAS No 61023-50-5 supplier

CASNo 61023-50-5 distributor

CAS # 61023-50-5 manufacturer

CAS Number 61023-50-5 safety

CAS RN 61023-50-5 wholesale

2026-10-15 1H-Imidazole, 1-(1-methyl-1-phenylpentyl)-,CAS No.61023-50-5,Formula:C15H20N2. Find Related Products for Bulk Production or Scientific Research